Geode Capital Management’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-38,037
Closed -$170K – 4576
2024
Q3
$170K Buy
38,037
+9,729
+34% +$64.9K ﹤0.01% 3956
2024
Q2
$170K Sell
28,308
-488
-2% -$2.56K ﹤0.01% 3974
2024
Q1
$237K Buy
28,796
+4,870
+20% +$26K ﹤0.01% 3884
2023
Q4
$120K Hold
23,926
– – ﹤0.01% 4126
2023
Q3
$145K Buy
23,926
+3,251
+16% +$29.1K ﹤0.01% 4108
2023
Q2
$287K Hold
20,675
– – ﹤0.01% 3877
2023
Q1
$244K Hold
20,675
– – ﹤0.01% 3947
2022
Q4
$403K Buy
20,675
+719
+4% +$12.2K ﹤0.01% 3774
2022
Q3
$283K Hold
19,956
– – ﹤0.01% 4020
2022
Q2
$482K Buy
19,956
+261
+1% +$7.26K ﹤0.01% 3787
2022
Q1
$683K Hold
19,695
– – ﹤0.01% 3786
2021
Q4
$567K Sell
19,695
-1
-0% -$39 ﹤0.01% 3976
2021
Q3
$974K Buy
19,696
+335
+2% +$16.8K ﹤0.01% 3687
2021
Q2
$981K Sell
19,361
-8,908
-32% -$449K ﹤0.01% 3613
2021
Q1
$1.62M Buy
28,269
+9,273
+49% +$604K ﹤0.01% 3359
2020
Q4
$854K Buy
18,996
+509
+3% +$24.5K ﹤0.01% 3410
2020
Q3
$931K Buy
18,487
+458
+3% +$24.8K ﹤0.01% 3240
2020
Q2
$1.1M Buy
18,029
+12,774
+243% +$773K ﹤0.01% 3116
2020
Q1
$199K Buy
5,255
+712
+16% +$31.1K ﹤0.01% 3556
2019
Q4
$211K Hold
4,543
– – ﹤0.01% 3775
2019
Q3
$197K Hold
4,543
– – ﹤0.01% 3772
2019
Q2
$202K Hold
4,543
– – ﹤0.01% 3789
2019
Q1
$242K Hold
4,543
– – ﹤0.01% 3680
2018
Q4
$212K Buy
+4,543
New +$261K ﹤0.01% 3655

Geode Capital Management's ORGS Position: Q4 2024 in Review

Geode Capital Management sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2024, closing a stake of 38,037 shares — an estimated $170K sold.

Geode Capital Management first reported a position in ORGS in Q4 2018 and held it in 24 quarters. The position peaked at $1.62M in Q1 2021. 0 funds tracked by Wall St. Rank hold ORGS as of Q4 2024.

  • Geode Capital Management reported no remaining Orgenesis Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Geode Capital Management sold 38,037 Orgenesis Inc. Common Stock shares in Q4 2024, an estimated $170K.
  • Geode Capital Management first reported a position in Orgenesis Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • Geode Capital Management's Orgenesis Inc. Common Stock position peaked at $1.62M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2024.

Based on Geode Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.